New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies – making them more vulnerable to a severe infection.
Invitae test for hereditary cancers gains FDA de novo nod
Dive Brief: Genetic testing company Invitae has received de novo authorization from the Food and Drug Administration for an in vitro diagnostic test that can
October 3, 2023